Use of [18F]FET PET-MRI to Improve Detection of Pituitary Adenomas in Cushing's Disease

NAEnrolling by invitationINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

July 30, 2029

Study Completion Date

July 30, 2029

Conditions
Cushing Disease
Interventions
DIAGNOSTIC_TEST

[18F]FET PET-MRI

All participants will undergo both \[18F\]fluoroethyltyrosine positron emission tomography-magnetic resonance imaging (\[18F\]FET-PET-MRI) and inferior petrosal sinus sampling (IPSS) as part of the diagnostic work-up for ACTH-dependent hypercortisolism. The purpose is to compare the diagnostic accuracy of these two modalities in distinguishing Cushing's disease from ectopic ACTH secretion. The results from both diagnostic tests will be communicated to the treating medical team and the participant to guide further clinical management.

Trial Locations (2)

3015

Erasmus University Medical Centre, Rotterdam

4031

University Hospital Basel, Basel

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Erasmus Medical Center

OTHER

lead

University Hospital, Basel, Switzerland

OTHER